Fertility Preserving Measures in Young People with Cancer - Ethical and Psychosocial Aspects of Information and Consent

Fertility Preserving Measures in Young People with Cancer - Ethical and Psychosocial Aspects of Information and Consent - FEON Fertility and Ethics in Oncology

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00029744

Enrollment

Registered

2023-03-02

Start date

2023-02-21

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C50 C51 C52 C53 C54 C55 C56 C57 C58 C61 C67

Interventions

Group 1: Study population: Patients undergoing chemotherapy with alkylating agents and radiation therapy in the abdominal or pelvic area, which includes the ovaries or uterus, prostate or testicles, o

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: - Patients (m/f) of reproductive age between 18-50 years and their partners. - first diagnosis of gynecological, hematological or breast cancer, sarcoma, prostate, testicular, rectal or anal carcinoma - Treatment started or completed (i.e., surgery, chemotherapy, radiation therapy [infradiaphragm and/or proximal lower extremities]; < 1 year after initiation of therapy)

Exclusion criteria

Exclusion criteria: - tumor relapse - advanced, metastatic cancer - severe psychiatric disorders - severe cognitive disorders that hinder or limit the completion of questionnaires - insufficient knowledge of German - completed childbearing

Design outcomes

Primary

Measure	Time frame
Optimizing future oncofertility counseling by identifying ethical and psychosocial aspects of counselling; patient participation; Creation of a counseling guide for patients and a checklist for experts.	—

Secondary

Measure	Time frame
Patient participation * Project planning and application: Patients were asked to review and comment on the documents. * Project implementation: Patients participate in project tasks and take part in regular meetings. * Implementation of the results: Patients actively participate in the interpretation of the results and the creation of guidelines for action in practice. The project results will then be published together with the patients.	—

Measure

Time frame

Patient participation * Project planning and application: Patients were asked to review and comment on the documents. * Project implementation: Patients participate in project tasks and take part in regular meetings. * Implementation of the results: Patients actively participate in the interpretation of the results and the creation of guidelines for action in practice. The project results will then be published together with the patients.

—

Countries

Germany

Contacts

Public ContactJoachim Weis

Medizinische Fakultät Albert-Ludwigs-Universität Freiburg, Tumorzentrum, CCCF

Joachim.Weis@uniklinik-freiburg.de+4976127071563

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026